Discovery Funding Opportunities
NIBIB Quantum Program: Technological Innovation to Solve a Major Medical or Public Health Challenge (U01)
Due Date: 01-26-2017
The goal of the program is to achieve a profound (quantum) advance over present-day approaches to the prevention, detection, diagnosis, and/or treatment of a major disease or national public health problem primarily through the development of biomedical engineering/biomedical imaging technologies.
American Heart Association Partner with Amazon's Cloud-computing Division to fund Institute for Precision Cardiovascular Medicine Grants
Due Date: 01-31-2017
Fourteen grants will be awarded over the next year to foster cross-disciplinary learning, enabling the scientific, mathematics, and technology communities to come together in support of precision cardiovascular medicine
Emory Medical Care Foundation
Due Date: 02-01-2017
The grants support the research careers of junior investigators and more senior investigators interested in pursuing research. The grant program is designed to provide financial support for clinical studies that are related to the healthcare needs of the patients served by Grady.
Alzheimer's Clinical Trials Consortium (ACTC) (U24)
Due Date: 02-02-2017
The ACTC will conduct clinical trials (Phase I to III) of promising pharmacological and non- pharmacological interventions for cognitive and neuropsychiatric symptoms in individuals with Alzheimer's disease and other age related dementias across the spectrum from pre-symptomatic to more severe stages of disease. The ACTC will provide a state-of-the-art clinical trial infrastructure to facilitate rapid development and implementation of protocols. The ACTC will also provide leadership to the field in innovative trial design methods, outcomes and analyses as well as recruitment strategies, particularly in diverse populations.
NIH-funded Georgia Center for Diabetes Translation Research: Pilot & Feasibility Funding
Due Date: 02-06-2017
Emory, in partnership with Georgia Tech and Morehouse School of Medicine, has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to establish the Georgia Center for Diabetes Translation Research (Georgia CDTR). In alignment with its mission to facilitate and grow diabetes translation research, pilot proposals are solicited that focus on Type II translational research in diabetes care and prevention.
Focused Technology Research & Development (R01)
Due Date: 02-06-2017
This NIH-NIGMS initiative will support projects that focus solely on development of technologies with the potential to enable biomedical research. Projects should be justified in terms of potential biomedical impact, but should not include any application to specific biomedical research questions.
Pediatric Technology Center Child Impact Grants
Due Date: 02-10-2017
Children¿s Healthcare of Atlanta and Georgia Tech are pleased to announce the availability of
this funding to stimulate new research projects, build new collaborations, and increase extramural funding for pediatric research. Faculty from all GRA-affiliated institutions are eligible.
Pilot Clinical Trials Targeting HIV-1 Reservoirs in Children (U01)
Due Date: 02-14-2017
The purpose of this FOA is to support pilot clinical trials that test interventions to limit or reduce HIV-1 reservoirs in children (birth to 18 years of age at the time of enrollment) on effective suppressive antiretroviral therapy.
Clinical Trials to Test the Effectiveness of Treatment, Preventive, & Services Interventions (Collaborative R01)
Due Date: 02-15-2017
This FOA seeks to support clinical trials to establish the effectiveness of interventions and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacologic, somatic, psychosocial (psychotherapeutic, behavioral), device-based, rehabilitative and combination interventions to prevent or treat mental illness.
Exploratory Research for Technology Development (R21)
Due Date: 02-16-2017
This NIH-NIGMS initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high-risk approaches with potential for significant impact. Projects will entail a high degree of risk and reward high-risk approaches with potential for significant impact.
Diabetes Research Centers (P30)
Due Date: 02-28-2017
This FOA invites applications for Diabetes Research Centers that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases.
NIH/NIDDK: Assay Development & Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01)
The goal of this FOA is to develop, validate, or conduct a screen using a novel assay to identify therapeutic or imaging agents relevant to health related outcomes of interest to the NIDDK. It is expected that state of the art measures of basic cellular processes or molecular events that are key mediators of disease pathogenesis are incorporated into these novel assays.
T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44)
Due Date: 02-28-2017
For the purposes of this FOA, T2 translational research on aging involves the development or evaluation of methods for disseminating (1) results from clinical studies into everyday clinical practice and health decision-making in geriatric medicine, (2) results from large scale behavioral and community interventions into practice in community organizations, workplaces, and public institutions, and (3) development of new technologies for enhancing research productivity in aging research.
Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01)
Due Date: 03-01-2017
The purpose of this FOA is to stimulate research in the area of PDAC microenvironment with the ultimate goal of understanding the interaction between tumors and the microenvironment. The plan is to design new immunotherapy and combination interventions that would accommodate and build on the distinct characteristics of this interaction.
NIH/NIAID/NIA: Investigator Initiated Extended Clinical Trial (R01)
Due Date: 03-07-2017
This FOA invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of six or seven years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs.
Opportunity to Sequence Pediatric Cohorts through the Kids First Program
Due Date: 03-07-2017
Kids First is soliciting applications (PAR-17-063) to identify samples for whole genome sequencing that will help to elucidate the genetic contribution to childhood cancers and structural birth defects. The Common Fund¿s Gabriella Miller Kids First Pediatric Research (Kids First) program is developing a data resource for the pediatric research community of clinical and genetic sequence data that will allow scientists to identify genetic pathways that underlie childhood cancer and structural birth defects and to explore whether shared genetic pathways exist between these conditions. Register for a pre-application webinar by Kids First program staff on January 23, from 3:00-4:00 p.m
Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)
Due Date: 03-03-2017
The purpose of this FOA is to invite applications to stimulate innovative collaborative research in the NCATS¿ Clinical and Translational Science Award (CTSA) consortium.
NSF BIGDATA Solicitation 2017
Due Date: 03-15-2017
The BIGDATA program seeks novel approaches in computer science, statistics, computational science, and mathematics, along with innovative applications in domain science.
Competitive Collaborative Projects for Human Islet Biology (UC4)
Due Date: 03-23-2017
This FOA solicits applications for collaborative research projects that will enhance the goals of the Human Islet Research Network (HIRN). The HIRN is a collaborative program consisting of multiple related but distinct research consortia focused around two common goals: increasing our understanding of how human beta cells are lost in Type 1 Diabetes, and finding innovative strategies to protect or replace functional beta cell mass in diabetic patients.
Exploratory CTSA Collaborative Innovation Awards (R21 Supplement)
Due Date: 03-29-2017
The purpose of This FOA is to support highly innovative, exploratory, collaborative research projects in the NCATS¿ Clinical and Translational Science Award (CTSA) program, with the goal of assessing utility and feasibility of proposed innovation(s). The opportunity offers $275K over two years. The opportunity is broad ¿ from microbiome to building a better trial.
National Lupus Outreach & Clinical Trial Education Program
Due Date: 03-31-2017
The National Lupus Outreach and Clinical Trial Education Program (¿Lupus Program¿) seeks to reduce lupus related health disparities among racial and ethnic minority and/or disadvantaged populations disproportionately affected by this disease by: implementing and assessing a national health education program on lupus; and developing, piloting, and assessing provider education interventions designed to increase minority participation in clinical trials for lupus and developing a plan for broader implementation of such interventions.
HHS Partnerships to Achieve Health Equity
Due Date: 03-31-2017
The Partnership to Achieve Health Equity (PAHE) program will support partnerships that involve an organization with a nationwide reach, focus or impact, and which includes addressing social determinants of health to achieve health equity for racial and ethnic minority and/or disadvantaged populations, through programs which: (1) Improve access to and utilization of care by racial and ethnic minority and/or disadvantaged populations; (2) Test models of disease management including health promotion and disease prevention for individuals with multiple chronic conditions that disparately affect racial and ethnic minorities and affect morbidity.
W. M. Keck Foundation: Request for Pre-application Abstracts
Due Date: 05-01-2017
The Keck Foundation Research Program supports projects in medical research and science and engineering that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. Both Senior and Early Career investigators are encouraged to apply.
Shared Instrumentation Grant (SIG) Program (S10)
Due Date: 05-31-2017
The program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000.
High-End Instrumentation (HEI) Grant Program (S10)
Due Date: 05-31-2017
The program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001.
Center of Excellence for Research on Complementary & Integrative Health (P01)
This FOA encourages the submission of applications that requires multi-project, synergistic collaboration between outstanding scientists that blends multiple research approaches by multi-disciplinary research teams.
NIH Health Care Systems Research Collaboratory: Demonstration Projects for Pragmatic Clinical Trials
Due Date: 06-02-2017
Trials must be conducted across two or more health care systems and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. Any ACTSI investigators interested in applying should contact Lance Waller to discuss biostatistical support.